RxDoctor Payments Data

Dixie Clement, MD

Family Medicine · Marksville, LANPI 1851517734

Payments from drug & device makers

$964in general payments, 2019–2025

Across 59 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$245
  • Lilly USA, LLC$159
  • AbbVie$150
  • Takeda Pharmaceuticals U.S.A., Inc.$99
  • Sanofi-aventis U.S. LLC$62
  • Kowa Pharmaceuticals America, Inc.$44
  • plus $206 from 10 others

What the payments were for

  • Food & beverage$964100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$964 in reported general payments places this provider in the 55th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$143,592
Medicare patients
374
Services billed
4,118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide115$110,664
TrulicityDulaglutide53$46,756
FarxigaDapagliflozin Propanediol48$38,132
MounjaroTirzepatide32$36,418
JardianceEmpagliflozin31$33,157
RybelsusSemaglutide11$19,657
EliquisApixaban21$14,299
JanuviaSitagliptin Phosphate12$11,248
XareltoRivaroxaban13$8,463
PremarinEstrogens, Conjugated23$6,945
TradjentaLinagliptin12$5,399
Pantoprazole Sodium181$4,278
Valsartan66$3,829
Gabapentin187$3,179
Atorvastatin Calcium246$3,031

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$245$130,321126 claims
Lilly USA, LLCTrulicity, Mounjaro$159$83,17485 claims
Boehringer IngelheimJardiance, Tradjenta$19$38,55643 claims
AstraZenecaFarxiga$42$38,13248 claims
AbbVieSynthroid$150$2,94242 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in Marksville

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →